Abstract | BACKGROUND:
Breast cancer is the most common female cancer worldwide. Large hypoxic area is one of the features of tumor microenvironment. Highly activated hypoxia-induced pathways positively correlate with poor clinical response to chemo- and radiotherapy and high mortality in breast cancer patients. PURPOSE: RESULTS:
Hypoxia-induced expression of a receptor tyrosine kinase EphB4 was observed in hypoxic breast cancer cell models. Sanguinarine, a natural alkaloid, could effectively combat hypoxia-induced EphB4 and HIF-1α expression. Sanguinarine inhibited the activation of downstream protein signal transducer and activator of transcription-3 (STAT3), thereby blocking hypoxia-induced HIF-1α/STAT3 interaction and downregulating the mRNA levels of their target genes. Mechanically, sanguinarine attenuated HIF-1α protein levels via inhibition of MAPK/ERK pathways and promotion of HIF-1α proteasome degradation. Sanguinarine inhibited STAT3 activation through targeting its upstream EphB4 and accelerating STAT3 dephosphorylation. Correspondingly, xenograft models confirmed that sanguinarine treatment disrupted hypoxia-induced pathways and inhibited tumor growth in vivo. CONCLUSIONS: Our results may bring insights to the hypoxia-induced pathways in breast cancers, and suggest sanguinarine as a promising candidate for EphB4 and HIF-1α-targeted inhibition.
|
Authors | Qi Su, Jingjing Wang, Qing Wu, Asmat Ullah, Mohsin Ahmad Ghauri, Ammar Sarwar, Li Chen, Feng Liu, Yanmin Zhang |
Journal | Phytomedicine : international journal of phytotherapy and phytopharmacology
(Phytomedicine)
Vol. 84
Pg. 153503
(Apr 2021)
ISSN: 1618-095X [Electronic] Germany |
PMID | 33636580
(Publication Type: Journal Article)
|
Copyright | Copyright © 2021 Elsevier GmbH. All rights reserved. |
Chemical References |
- Antineoplastic Agents, Phytogenic
- Benzophenanthridines
- EPHB4 protein, human
- HIF1A protein, human
- Hypoxia-Inducible Factor 1, alpha Subunit
- Isoquinolines
- STAT3 Transcription Factor
- STAT3 protein, human
- sanguinarine
- Receptor, EphB4
|
Topics |
- Animals
- Antineoplastic Agents, Phytogenic
(pharmacology)
- Benzophenanthridines
(pharmacology)
- Breast Neoplasms
(drug therapy, metabolism, pathology)
- Cell Line, Tumor
- Female
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Hypoxia-Inducible Factor 1, alpha Subunit
(genetics, metabolism)
- Isoquinolines
(pharmacology)
- Mice, Inbred BALB C
- Receptor, EphB4
(genetics, metabolism)
- STAT3 Transcription Factor
(metabolism)
- Tumor Hypoxia
(drug effects)
- Xenograft Model Antitumor Assays
|